Protalix BioTherapeutics Inc (PLX)
1.69
+0.03
(+1.81%)
USD |
NYAM |
Nov 22, 16:00
1.70
+0.01
(+0.59%)
After-Hours: 20:00
Protalix BioTherapeutics Total Return Price: 1.69 for Nov. 22, 2024
Total Return Price Chart
Historical Total Return Price Data
Date | Value |
---|---|
November 22, 2024 | 1.69 |
November 21, 2024 | 1.66 |
November 20, 2024 | 1.69 |
November 19, 2024 | 1.63 |
November 18, 2024 | 1.66 |
November 15, 2024 | 1.40 |
November 14, 2024 | 1.41 |
November 13, 2024 | 1.24 |
November 12, 2024 | 1.32 |
November 11, 2024 | 1.20 |
November 08, 2024 | 1.16 |
November 07, 2024 | 1.16 |
November 06, 2024 | 1.22 |
November 05, 2024 | 1.30 |
November 04, 2024 | 1.28 |
November 01, 2024 | 1.25 |
October 31, 2024 | 1.17 |
October 30, 2024 | 1.17 |
October 29, 2024 | 1.17 |
October 28, 2024 | 1.13 |
October 25, 2024 | 1.08 |
October 24, 2024 | 1.03 |
October 23, 2024 | 1.02 |
October 22, 2024 | 1.06 |
October 21, 2024 | 1.06 |
Date | Value |
---|---|
October 18, 2024 | 1.09 |
October 17, 2024 | 1.09 |
October 16, 2024 | 1.09 |
October 15, 2024 | 1.08 |
October 14, 2024 | 1.06 |
October 11, 2024 | 1.08 |
October 10, 2024 | 1.00 |
October 09, 2024 | 1.01 |
October 08, 2024 | 1.02 |
October 07, 2024 | 1.02 |
October 04, 2024 | 1.08 |
October 03, 2024 | 1.01 |
October 02, 2024 | 1.02 |
October 01, 2024 | 1.05 |
September 30, 2024 | 1.02 |
September 27, 2024 | 1.05 |
September 26, 2024 | 1.07 |
September 25, 2024 | 1.09 |
September 24, 2024 | 1.08 |
September 23, 2024 | 1.12 |
September 20, 2024 | 1.10 |
September 19, 2024 | 1.15 |
September 18, 2024 | 1.09 |
September 17, 2024 | 1.10 |
September 16, 2024 | 1.09 |
Total Return Price Definition
The total return price allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions.
Total Return Price Range, Past 5 Years
0.81
Minimum
Jan 27 2022
6.45
Maximum
Feb 09 2021
2.094
Average
1.58
Median
Jul 15 2021
Total Return Price Benchmarks
Accuray Inc | 1.93 |
Aethlon Medical Inc | 0.4043 |
AIM ImmunoTech Inc | 0.2101 |
Perspective Therapeutics Inc | 3.47 |
Armata Pharmaceuticals Inc | 2.25 |